Photobiomodulation on Core Symptoms of Autism
ConditionAutism
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-6
SponsorSuez University
About this trial
This study aims to evaluate the effectiveness of photobiomodulation therapy on core symptoms in children with autism spectrum disorder. Participants will receive designed physical therapy, occupational therapy and speech program in addition to Photobiomodulation over a defined period. Out comes will be assessed using standardized clinical scales to determine improvements in social interactions, communication and behavior.
Eligibility criteria
Qualifiers
Children with autism spectrum disorders (ASD).
Their age ranged from 2 to 6 years
Disqualifiers
Children having epileptogenic seizures.
Mentally retarded children.
Children with genetic syndromes.
Trial design
Treatments tested in this trial
- Photobiomodulation
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov